Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy

被引:212
作者
Montravers, P
Gauzit, R
Muller, C
Marmuse, JP
Fichelle, A
Desmonts, JM
机构
[1] HOP BICHAT, DEPT ANESTHESIE REANIMAT CHIRURG, MICROBIOL LAB, F-75877 PARIS, FRANCE
[2] HOP BICHAT, SERV CHIRURG GEN, F-75877 PARIS, FRANCE
关键词
D O I
10.1093/clinids/23.3.486
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In cases of community-acquired peritonitis, the adequacy of empirical antibiotic treatment has been shown to attenuate mortality and morbidity. The impact of empirical antibiotics on the outcome of postoperative peritonitis has never been evaluated. This study included 100 consecutively studied patients with postoperative peritonitis. The adequacy of empirical treatment was determined by means of culture and susceptibility data obtained at the time of reoperation, and the effect of such treatment on outcome was evaluated. One hundred resistant pathogens were isolated from 70 patients, of whom 45% died; by comparison, mortality among those from whom susceptible organisms were isolated was 16% (P < .05). Inadequate empirical treatment was administered to 54 patients and was associated with poorer outcome (P less than or equal to .05). The outcome of postoperative peritonitis is affected by the choice and adequacy of the initial empirical antibiotic therapy. Late changes in antibiotic therapy based on culture results did not affect outcome when the initial regimen was inadequate.
引用
收藏
页码:486 / 494
页数:9
相关论文
共 28 条
[1]  
ACAR J, 1991, PATHOL BIOL PARIS, V39, P737
[2]  
Acar J., 1985, ANTIBIOTICS LABORATO, P27
[3]   OPPORTUNISTIC NOSOCOMIAL MULTIPLY RESISTANT BACTERIAL-INFECTIONS - THEIR TREATMENT AND PREVENTION [J].
BERGOGNEBEREZIN, E ;
DECRE, D ;
JOLYGUILLOU, ML .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 :39-47
[4]  
BOHNEN J, 1983, ARCH SURG-CHICAGO, V118, P285
[5]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[6]   HIGH-LEVEL PENICILLIN RESISTANCE AMONG ISOLATES OF ENTEROCOCCI - IMPLICATIONS FOR TREATMENT OF ENTEROCOCCAL INFECTIONS [J].
BUSH, LM ;
CALMON, J ;
CHERNEY, CL ;
WENDELER, M ;
PITSAKIS, P ;
POUPARD, J ;
LEVISON, ME ;
JOHNSON, CC .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (07) :515-520
[7]  
CALANDRA T, 1989, LANCET, V2, P1437, DOI 10.1016/S0140-6736(89)92043-6
[8]   TIMENTIN IN THE ANTIMICROBIAL TREATMENT OF NOSOCOMIAL AND POLYMICROBIAL INFECTIONS [J].
CARLET, J ;
GOLDSTEIN, FW ;
BLERIOT, JP ;
BAHLOUL, F ;
DAZZA, FE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 :149-159
[9]  
FINEGOLD SM, 1990, REV INFECT DIS, V12, pS223
[10]   SCREENING AND TREATMENT OF INFECTIONS CAUSED BY RESISTANT ENTEROCOCCI [J].
HERMAN, DJ ;
GERDING, DN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) :215-219